TIGIT and neoplasm: These data are consistent with transcriptomic observations from the analyses by Wen et al. and Zaravinos et al., who reported positive associations between TIGIT expression, MSI-related signatures, tumor mutational burden, and immune cytolytic activity in CRC [34,35].